The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Clifford J. Bailey

School of Life and Health Sciences

Aston University

Gosta Green

Birmingham B4 7ET



Name/email consistency: high



  • School of Life and Health Sciences, Aston University, Gosta Green, Birmingham B4 7ET, UK. 2002 - 2012


  1. Diabetes: Insulin plus metformin for T2DM-are there benefits? Bailey, C.J. Nat. Rev. Endocrinol (2012) [Pubmed]
  2. Could FFAR1 assist insulin secretion in type 2 diabetes? Bailey, C.J. Lancet (2012) [Pubmed]
  3. Patient adherence to medication requirements for therapy of type 2 diabetes. Bailey, C.J., Kodack, M. Int. J. Clin. Pract. (2011) [Pubmed]
  4. Renal glucose reabsorption inhibitors to treat diabetes. Bailey, C.J. Trends Pharmacol. Sci. (2011) [Pubmed]
  5. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. Bailey, C.J., Gross, J.L., Pieters, A., Bastien, A., List, J.F. Lancet (2010) [Pubmed]
  6. Inhaled insulin: new formulation, new trial. Bailey, C.J., Barnett, A.H. Lancet (2010) [Pubmed]
  7. Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazone. Bailey, C.J., Green, B.D., Flatt, P.R. Expert. Opin. Investig. Drugs (2010) [Pubmed]
  8. New therapies for diabesity. Bailey, C.J. Curr. Diab. Rep. (2009) [Pubmed]
  9. Fixed-dose single tablet antidiabetic combinations. Bailey, C.J., Day, C. Diabetes. Obes. Metab (2009) [Pubmed]
  10. What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management. Bailey, C.J., Blonde, L., Del Prato, S., Leiter, L.A., Nesto, R. Diab. Vasc. Dis. Res (2009) [Pubmed]
  11. Metformin: effects on micro and macrovascular complications in type 2 diabetes. Bailey, C.J. Cardiovasc. Drugs. Ther (2008) [Pubmed]
  12. Treating insulin resistance: future prospects. Bailey, C.J. Diab. Vasc. Dis. Res (2007) [Pubmed]
  13. Drugs on the horizon for diabesity. Bailey, C.J. Curr. Diab. Rep. (2005) [Pubmed]
  14. Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control. Bailey, C.J., Del Prato, S., Eddy, D., Zinman, B. Int. J. Clin. Pract. (2005) [Pubmed]
  15. Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week, multicenter, randomized, double-blind, parallel-group study. Bailey, C.J., Bagdonas, A., Rubes, J., McMorn, S.O., Donaldson, J., Biswas, N., Stewart, M.W. Clin. Ther (2005) [Pubmed]
  16. Glucosamine-induced insulin resistance in L6 muscle cells. Bailey, C.J., Turner, S.L. Diabetes. Obes. Metab (2004) [Pubmed]
  17. Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes. Bailey, C.J., Day, C. Int. J. Clin. Pract. (2004) [Pubmed]
  18. Future therapies. Bailey, C.J., Day, C. Curr. Med. Res. Opin (2002) [Pubmed]
WikiGenes - Universities